Literature DB >> 32548621

The first case report of polymerase proofreading-associated polyposis in POLD1 variant, c.1433G>A p.S478N, in Japan.

Tetsuya Ito1, Tadashi Nomizu2, Hidetaka Eguchi3, Nao Kamae4, Sariya Dechamethakun3, Yoshinori Akama5, Goichi Endo6, Kokichi Sugano7, Teruhiko Yoshida8, Yasushi Okazaki3, Hideyuki Ishida1.   

Abstract

Polymerase proofreading-associated polyposis, caused by germline variants in the exonuclease domains of POLD1 and POLE, is a dominantly inherited rare condition characterized by oligo-adenomatous polyposis and increased risk of colorectal cancer, endometrial cancer and brain tumours. We report the first Japanese case of polymerase proofreading-associated polyposis carrying a POLD1 variant. The proband was a Japanese woman who had undergone resections of early colorectal carcinomas repeatedly and a hysterectomy with bilateral oophorectomy for endometrial cancer, all of which were diagnosed within 2 years after the first colectomy at 49 year old. Colonoscopic examinations demonstrated at least 14 non-cancerous polypoid lesions, some of which were histologically confirmed to be adenoma. Multigene panel sequencing identified a missense variant in POLD1 (c.1433G>A). Although her relatives did not undergo genetic testing, her father and paternal grandfather died of brain tumours at 53 and ~30 years of age, respectively.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 POLD1zzm321990 ; endometrial cancer; hereditary colorectal cancer; polyposis

Mesh:

Substances:

Year:  2020        PMID: 32548621     DOI: 10.1093/jjco/hyaa090

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  1 in total

1.  Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Shuai Zhao; Cuicui Wei; Haijia Tang; Han Ding; Bing Han; Shuxian Chen; Xiaoling Song; Qiang Gu; Yichi Zhang; Wangrui Liu; Jian Wang
Journal:  Front Oncol       Date:  2021-11-11       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.